Drugs / HRIG
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT03264157 | Dec 2017 → Mar 2018 | — | Bio Products Laboratory | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | HRIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03264157 ↗ |
| Route | Intramuscular | “via IM injection” NCT03264157 ↗ |